NL-OMON26939CompletedNot Applicable
Pregabalin in Patients with Central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen.
Academic Medical Center, AmsterdamDepartment of anesthesiologyPain Relief Unit0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Age 18 years or older;
- •2. Written informed consent;
Exclusion Criteria
- •1. Pregnant;
- •2. Had a history of intolerance, hypersensitivity, or known allergy to pregabalin;
Investigators
Similar Trials
Completed
Not Applicable
Pregabalin in patients with central neuropathic pain: a randomised, double-blind, placebo-controlled trial of a flexible-dose regimeISRCTN67414160Academic Medical Center (AMC) (Netherlands)40
Not yet recruiting
Not Applicable
The clinical effect of pregabalin on neuropathic pain in central sensitized patients who are treated with duloxetine after total knee arthroplasty: Randomized Controlled TrialKCT0007301The Catholic University of Korea, Seoul St. Mary's Hospital90
Not yet recruiting
Not Applicable
The clinical effect of Pregabalin on neuropathic pain in non central sensitized patients after total knee arthroplasty: Randomized Controlled TrialDiseases of the musculoskeletal system and connective tissueKCT0007325The Catholic University of Korea, Seoul St. Mary's Hospital90
Completed
Not Applicable
Impact of pregabalin in chronic neuropathic pain after lung resectioAll diseases required lung resectionJPRN-UMIN000007757Department of General Thoracic and Cardiovascular Surgery, University of Toyama200
Not yet recruiting
Not Applicable
The efficancy of pregabalin for peripheral neuropathic pain in spinal diseasespinal diseaseJPRN-UMIN000005938Okayama University Hospital,Dept.of Orthop.Surg.100